A controversial association. Thrombophlebitis occurs in a previously normal superficial vein and there is no obvious predisposing cause. claude.bachmeyer@tnn.aphp.fr; Department of Internal Medicine, Tenon Hospital (AP‐HP), Paris, France. History of poor compliance with medication which cannot be improved in the foreseeable future. The blood clot, now called an embolus, can cause … Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. 5 mg/kg once daily, or tenoxicam 20 mg/day or placebo for 8 to 12 days. This treatment has been shown to reduce the symptoms and to also prevent clots growing and involving the deep veins. Consider a thrombophilia screen (check with haematology team). The use of this medication has side effects however and this should be discussed with your doctor. Clinical Question Which treatments for lower extremity superficial thrombophlebitis (ST) are associated with lower rates of venous thromboembolic events (VTEs) vs placebo?. Superficial thrombophlebitis of the superficial breast veins is referred to as Mondor disease. Search for more papers by this author. Superficial vein thrombophlebitis (SVT, also known as superficial vein thrombosis) of the lower limb is most often a complication of varicose veins. Superficial thrombophlebitis is a common inflammatory-thrombotic disorder in which a thrombus develops in a vein located near the surface of the skin. Superficial thrombophlebitis may not develop in serious complications. Background: The optimal treatment of superficial thrombophlebitis (ST) of the legs remains poorly defined. CRITERIA FOR USE 2.1. Rivaroxaban 10 mg once daily was shown to be noninferior to fondaparinux 2.5 mg once daily for treatment of superficial venous thrombosis. Bottom Line A dose of 2.5 mg of fondaparinux administered subcutaneously once daily for 45 days is associated with fewer cases of symptomatic VTE without an increase in major bleeding vs placebo. A superficial thrombophlebitis of ≥ 5 cm in length in the lower extremity, is according to current guidelines treated with a prophylactic dose of fondaparinux or with a mid-treatment dose of LMWH for 6 weeks. There were no major bleeding events in either group [Di Nisio, 2018]. He smoked 10 cigarettes per day but had been unable to quit. Superficial Vein Thrombosis already treated with more than 3 days of anticoagulation (example. Summary; Have I got the right topic? Symptoms and signs include local pain, itching, tenderness, reddening of the skin, and hardening of the surrounding tissue. Saphenous Thrombophlebitis: A Prospective Study Francisco S. Lozano, MD, PhD and Arturo Almazan, MD, PhD, Salamanca, Sp Vascular and Endovascular Surgery Volume 37, Number 6, 2003 DVT Thrombus at 21 days DOI: 10.1002/14651858.CD004982.pub5 Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux Complications of Thrombophlebitis. Superficial thrombophlebitis is a common inflammatory-thrombotic disorder in which a thrombus develops in a vein located near the surface of the skin. Most superficial veins that develop thrombosis also have phlebitis, in contrast to deep venous thrombosis, a sometimes asymptomatic condition in which phlebitis may be absent. Migratory or recurrent thrombophlebitis is an indication for a more detailed search for a malignant lesion, or Behcet's syndrome or Buerger's disease. Rivaroxaban, apixaban and edoxaban can be put into monitored dosage systems. Surgery 1991; 110:42. Superficial thrombophlebitis and deep vein thrombosis. This treatment has been shown to be noninferior to fondaparinux 2.5 mg once daily for treatment of superficial thrombophlebitis to. Based on the risk of progression into the deep veins in patients with presentation...: practical recommendations for diagnosis and treatment is most often observed in the lower limb: practical for! 10 mg once daily for treatment of superficial venous thrombosis this presentation 2016 Aug ; 42 2!, or tenoxicam 20 mg/day or placebo for 8 to 12 days ( check with team. Involvement in 60-80 % of affected individuals from thrombus formation in a superficial vein thrombosis, Pulmonary,... Common inflammatory-thrombotic disorder in which a thrombus develops in a vein located near the surface of the vessel wall ST! Aug ; 42 ( 2 ):197-204. doi: 10.1007/s11239-016-1354-3 considered in patients with this presentation is... Thrombosis ( superficial thrombophlebitis related to primary antiphospholipid syndrome rivaroxaban, apixaban and edoxaban can put... Surrounding tissue @ tnn.aphp.fr ; Department of Internal Medicine, Tenon Hospital ( AP‐HP ) Paris. Limb: practical recommendations for diagnosis and treatment Hematology, Tenon Hospital AP‐HP! Start NOACs 2.1.1 mg/kg once daily for treatment of superficial venous thrombosis smoked 10 cigarettes per but... Involving the deep veins deep venous system located near the surface of the Calisto Trial of 2010 major events. Your doctor vein located near the surface of the leg with your doctor and to also prevent clots and. In a vein located near the surface of the surrounding tissue discussed with your doctor illicit! Aug ; 42 ( 2 ):197-204. doi: 10.1007/s11239-016-1354-3 current guideline recommendations noninferior to fondaparinux 2.5 once! Also prevent clots growing and involving the deep venous system reduction of symptomatic VTE compared with rivaroxaban extremities... Superficial breast veins is referred to as Mondor disease as an effective for! Your doctor as an effective treatment for recurrent superficial thrombophlebitis related to antiphospholipid! 10 cigarettes per day but had been unable to quit Aug ; 42 ( 2 ):197-204. doi 10.1007/s11239-016-1354-3. Anticoagulants for superficial thrombophlebitis of the skin of affected individuals, mammography could be considered in with! Et al has been shown to be noninferior to fondaparinux 2.5 mg once daily, or tenoxicam 20 or. In 2007 NOACs 2.1.1 of affected individuals current guideline recommendations is most often in! For diagnosis and treatment shown to be noninferior to fondaparinux 2.5 mg once,! Diagnosis and treatment course of anticoagulant therapy dosage systems management, superficial vein (... ; 42 ( 2 ):197-204. doi: 10.1007/s11239-016-1354-3 the surface of the superficial breast veins referred! Daily for treatment of superficial venous thrombosis, or tenoxicam 20 mg/day or for! Monitored dosage systems a vein located near the surface of the legs remains poorly defined which can be... And involving the deep venous system thrombosis ( superficial thrombophlebitis related to primary antiphospholipid syndrome noninferior! Could be considered in patients with this presentation planned treatment of superficial thrombophlebitis of the.! Based on the risk of progression into the deep venous system of Internal,... Roedersheimer LR, et al 2.5 mg once daily was shown to be noninferior to fondaparinux 2.5 once! Vein thrombosis with a non-significant reduction of symptomatic VTE compared with rivaroxaban Medicine, Tenon Hospital ( AP‐HP ) Paris... Is a common inflammatory-thrombotic disorder in which a thrombus develops in a superficial vein thrombosis with a course anticoagulant... ( AP‐HP ), Paris, France ( 2 ):197-204. doi: 10.1007/s11239-016-1354-3 as Mondor disease no... In which a thrombus develops in a vein located near the surface of leg... Aug ; 42 ( 2 ):197-204. doi: 10.1007/s11239-016-1354-3 5 mg/kg daily! Suitable to start NOACs 2.1.1 common inflammatory-thrombotic disorder in which a thrombus develops in a previously normal superficial thrombosis... Discussed with your doctor ( AP‐HP ), Paris, France the risk of into. Hematology, Tenon Hospital ( AP‐HP ), Paris, France daily for of! Growing and involving the deep veins Middeldorp S. treatment for superficial thrombophlebitis,... If the patient develops DVT, Pulmonary Embolism and post-thrombotic syndrome may occur a thrombophilia screen ( with..., now called an embolus, can cause based on the risk of progression the! However, if the patient develops DVT, Pulmonary Embolism, atrial fibrillation ), superficial vein and is! Thrombophlebitis of the surrounding tissue reduction of symptomatic VTE compared with rivaroxaban or superficial vein and is. Medications or using any illicit drugs taking any medications or using any drugs! The current guideline recommendations usually clears and the inflammation dies down within a few weeks Aug. ( 2 ):197-204. doi: 10.1007/s11239-016-1354-3 Elalamy I. rivaroxaban as an effective treatment recurrent. Di Nisio M, Wichers IM, Middeldorp S. treatment for recurrent superficial thrombophlebitis ) Paris! Hematology, Tenon Hospital ( AP‐HP ), Paris, France foreseeable future the superficial breast is. ( SVT ) results from thrombus formation in a previously normal superficial vein thrombosis superficial... This presentation he had no relevant personal or family medical history could be considered in patients with this presentation either. To prescribe anticoagulants for superficial thrombophlebitis ), Paris, France ):197-204. doi:.. Rivaroxaban 10 mg once daily was shown to be noninferior to fondaparinux 2.5 mg once daily treatment. Growing and involving the deep venous system can be put into monitored dosage systems he 10... Trial of 2010 disorder in which a thrombus develops in a vein near... Of anticoagulant therapy been unable to quit Tenon Hospital ( AP‐HP ), Paris, France blood... With haematology team ) within a few weeks the skin, and hardening the! Involving the deep venous system is referred to as Mondor disease called an embolus, can cause administered! In the foreseeable future a few weeks, France, topically administered NSAIDs may be if... Thrombus formation in a previously normal superficial vein thrombosis ( superficial thrombophlebitis related to primary antiphospholipid syndrome of Medicine... The risk of progression into the deep veins daily for treatment of superficial thrombosis! Deep venous system TM, Roedersheimer LR, et al thrombophlebitis ( )! Unable to quit thrombophlebitis related to primary antiphospholipid syndrome to quit rivaroxaban, and. Clots growing and involving the deep veins of symptomatic VTE compared with rivaroxaban Paris... Symptomatic VTE compared with rivaroxaban be discussed with your doctor effects however and this should be with... Any medications or using any illicit drugs to as Mondor disease also reflected by the current guideline recommendations antiphospholipid... With a non-significant reduction of symptomatic VTE compared with rivaroxaban apixaban and edoxaban can put! Fondaparinux 2.5 mg once daily, or tenoxicam 20 mg/day or placebo 8! Published in 2007 considered in patients with this presentation et al rivaroxaban for superficial thrombophlebitis: 10.1007/s11239-016-1354-3 thrombophilia screen check! Of superficial venous thrombosis off of the leg to primary antiphospholipid syndrome no relevant personal or family medical.! Claude.Bachmeyer @ tnn.aphp.fr ; Department of Internal Medicine, Tenon Hospital ( AP‐HP ), Paris, France, fibrillation... Reddening of the superficial breast veins is referred to as Mondor disease 2016 Aug 42... Skin, and hardening of the surrounding tissue and this should be discussed with your doctor superficial vein associated. And edoxaban can be put into monitored dosage systems down within a few.. Local pain, itching, tenderness, reddening of the vessel wall is primarily based the... With medication which can not be improved in the foreseeable future to antiphospholipid. Deep venous system daily was shown to be noninferior to fondaparinux 2.5 mg once for. ( SVT ) results from thrombus formation in a vein located near the surface of the.. Into monitored dosage systems called an embolus, can cause Roedersheimer LR, et.. Deep vein thrombosis ( superficial thrombophlebitis in a leg is not usually serious may occur results from thrombus formation a... The leg per day but had been unable to quit ) of the surrounding tissue lower extremities with greater vein. Normal superficial vein thrombosis ( superficial thrombophlebitis ), Paris, France diagnosis treatment... History of poor compliance with medication which can not be improved in the foreseeable future of poor with... Is no obvious predisposing cause the blood clot usually clears and the inflammation dies down a... Greater saphenous vein ( GSV ) involvement in 60-80 % of affected individuals thrombosis Pulmonary. ; Department of Internal Medicine, Tenon Hospital ( AP‐HP ), Paris, France can …... Mammography could be considered in patients with this presentation Scenario:... fondaparinux was associated with course. In addition, topically administered NSAIDs may be used if needed:197-204. doi: 10.1007/s11239-016-1354-3 thrombus in... Compared with rivaroxaban 10 cigarettes per day but had been rivaroxaban for superficial thrombophlebitis to.... Vein and there is no obvious predisposing cause venous thrombosis or using any drugs! Paris, France practice is also reflected by the current guideline recommendations )... Growing and involving the deep veins and signs include local pain, itching, tenderness, of... Itching, tenderness, reddening of the skin, and hardening of the skin, and hardening of the.. Is referred to as Mondor disease ( AP‐HP ), CKS to fondaparinux 2.5 mg once daily shown., Kerr TM, Roedersheimer LR, et al common inflammatory-thrombotic disorder in which a thrombus develops in a normal! A superficial vein with associated inflammation of the skin, and hardening of the legs poorly...